84
Participants
Start Date
January 31, 2015
Primary Completion Date
October 31, 2016
Study Completion Date
October 31, 2016
solithromycin
Sofia
Plovdiv
Rousse
Brooklyn
Albany
Baltimore
Richmond
Morgantown
Chapel Hill
Jacksonville
Tampa
Nashville
Louisville
Toledo
Cleveland
Iowa City
Milwaukee
Chicago
St Louis
Wichita
Omaha
Shreveport
Little Rock
Houston
Splendora
Austin
Albuquerque
San Diego
Orange
Palo Alto
Portland
Seattle
Hackensack
Memphis
Lead Sponsor
Department of Health and Human Services
FED
Melinta Therapeutics, Inc.
INDUSTRY